go to contents

Akribes Biomedical GmbH

Back to list

Facts

Founded
Staff
5
Organization type
RDM medtech

Profile

Development of a new pharmacological treatment for chronic wounds, identified by implementation of the first assay platform for personalized medicine of chronic wounds. The proprietary assays combine diagnosis and therapy recommendations for individual chronic wound patients. A Ph1b/2a proof-of-concept study is planned for 2025.

Similar companies in RDM medtech

Eurolyser Diagnostica GmbH

Organization type
RDM medtech
Region
Salzburg
Cluster
Medical Technology Cluster
Topic
in vitro diagnostic devices
telemedicine and e-health
software for medicine
Details

FT Medizintechnik GmbH

Organization type
RDM medtech
Region
Tyrol
Topic
hospital hardware
Details

MyMind GmbH

Organization type
RDM medtech
Region
Vienna
Topic
telemedicine and e-health
software for medicine
Details

MacroArray Diagnostics GmbH

Organization type
RDM medtech
Region
Vienna
Cluster
LISAvienna
Topic
in vitro diagnostic devices
telemedicine and e-health
software for medicine
Details

Contact



Contact: